GTAB B — Glycorex Transplantation AB (publ) Balance Sheet
0.000.00%
Last trade - 00:00- SEK142.73m
- SEK134.73m
- SEK35.16m
- 66
- 11
- 11
- 16
Annual balance sheet for Glycorex Transplantation AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 49.3 | 42.1 | 33.6 | 13.9 | 6.75 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.92 | 3.77 | 5.67 | 4.9 | 5.94 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 57.9 | 50.6 | 45.4 | 26.1 | 18.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11.4 | 10.9 | 12.7 | 17.1 | 12.7 |
| Net Intangible Assets | |||||
| Total Assets | 113 | 102 | 96.1 | 65.8 | 50.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11.4 | 13.5 | 15.8 | 14.5 | 14.2 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 17.5 | 18.8 | 21.7 | 21.8 | 17.2 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 95.2 | 83 | 74.4 | 44 | 33.1 |
| Total Liabilities & Shareholders' Equity | 113 | 102 | 96.1 | 65.8 | 50.3 |
| Total Common Shares Outstanding |